ConductScience.org, home
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
API referenceFor AI assistants

Trial · NCT01767155

Adverse events32

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 32

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherNeutropeniaBlood and lymphatic system disordersAEZS-108 / Zoptarelin Doxorubicin132252
otherNeutropeniaBlood and lymphatic system disordersDoxorubicin/ Standard Chemotherapy126249
otherNauseaGastrointestinal disordersAEZS-108 / Zoptarelin Doxorubicin120252
otherNauseaGastrointestinal disordersDoxorubicin/ Standard Chemotherapy125249
otherAneamiaBlood and lymphatic system disordersAEZS-108 / Zoptarelin Doxorubicin107252
otherAneamiaBlood and lymphatic system disordersDoxorubicin/ Standard Chemotherapy101249
seriousNeutropeniaBlood and lymphatic system disordersAEZS-108 / Zoptarelin Doxorubicin21252
seriousNeutropeniaBlood and lymphatic system disordersDoxorubicin/ Standard Chemotherapy15249
seriousAnemiaBlood and lymphatic system disordersAEZS-108 / Zoptarelin Doxorubicin16252
seriousAnemiaBlood and lymphatic system disordersDoxorubicin/ Standard Chemotherapy9249
seriousFebrile neutropeniaBlood and lymphatic system disordersAEZS-108 / Zoptarelin Doxorubicin17252
seriousFebrile neutropeniaBlood and lymphatic system disordersDoxorubicin/ Standard Chemotherapy8249
seriousThrombocytopeniaBlood and lymphatic system disordersAEZS-108 / Zoptarelin Doxorubicin8252
seriousThrombocytopeniaBlood and lymphatic system disordersDoxorubicin/ Standard Chemotherapy3249
seriousNauseGastrointestinal disordersAEZS-108 / Zoptarelin Doxorubicin11252
seriousNauseGastrointestinal disordersDoxorubicin/ Standard Chemotherapy8249
seriousVomitingGastrointestinal disordersAEZS-108 / Zoptarelin Doxorubicin7252
seriousVomitingGastrointestinal disordersDoxorubicin/ Standard Chemotherapy9249
seriousLeukopeniaBlood and lymphatic system disordersAEZS-108 / Zoptarelin Doxorubicin4252
seriousLeukopeniaBlood and lymphatic system disordersDoxorubicin/ Standard Chemotherapy6249

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01767155/events

API referenceFor AI assistants